Prognostic factors for patients with brain metastases – after whole brain radiotherapy

In this MEDtalk, Olav Yri, MD, Post doc., PhD, Department of Oncology, Oslo University Hospital presents data from a population-based prospective observational study at four hospitals in Norway. The patients who were included in the study were newly diagnosed with brain metastases from solid cancers and they were treated with whole brain radiotherapy.